AMODIAQUINE AND COMBINATION CHEMOTHERAPY FOR MALARIA

STEVEN R. MESHNICK Department of Epidemiology, University of North Carolina School of Public Health

Search for other papers by STEVEN R. MESHNICK in
Current site
Google Scholar
PubMed
Close
and
ALISA P. ALKER Department of Epidemiology, University of North Carolina School of Public Health

Search for other papers by ALISA P. ALKER in
Current site
Google Scholar
PubMed
Close
Restricted access

Author Notes

  • 1

    Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR, 2002. Epidemiology of drug-resistant malaria. Lancet Infect Dis 2 :209–218.

  • 2

    Danis M, Bricaire F, 2003. The new drug combinations: their place in the treatment of uncomplicated Plasmodium falciparum malaria. Fundam Clin Pharmacol 17 :155–160.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    White NJ, Nosten F, Looareesuwan S, Watkins WM, Snow RW, Kokwaro G, Ouma J, Hien TT, Molyneux ME, Taylor TE, Newbold CI, Ruebush TK 2nd, Danis M, Greenwood BM, Anderson RM, Olliaro P, 1999. Averting a malaria disaster. Lancet 353 :1965–1967.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Lankoande M, Ouedraogo JB, Rosenthal PJ, 2005. Amodiaquine, sulfadoxine-pyrimethamine, and combination therapy for uncomplicated falciparum malaria: a randomized controlled trial from Burkino Faso. Am J Trop Med Hyg 73 :826–832.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Chulay JD, Watkins WM, Sixsmith DG, 1984. Synergistic anti-malarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am J Trop Med Hyg 33 :325–330.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Srivastava IK, Vaidya AB, 1999. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob Agents Chemother 43 :1334–1339.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    White NJ, 2004. Antimalarial drug resistance. J Clin Invest 113 :1084–1092.

  • 8

    Attaran A, Barnes KI, Curtis C, D’Alessandro U, Fanello CI, Galinski ME, Kokwaro G, Looareesuwan S, Makanga M, Mutabingwa TK, Talisuna A, Trape JF, Watkins WM, 2004. WHO, the Global Fund, and medical malpractice in malaria treatment. Lancet 363 :237–240.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    Rojanawatsirivej C, Vijaykadga S, Amklad I, Wilairatna P, Looareesuwan S, 2003. Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 34 :536–541.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Clark RL, White TE, 2004. S AC, Gaunt I, Winstanley P and Ward SA. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Birth Defects Res B Dev Reprod Toxicol 71 :380–394.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Anonymous, End decade databases—Fertility and Contraceptive Use. Vol. 2005: UNICEF Statistics

    • PubMed
    • Export Citation
  • 12

    Steck EA, The Chemotherapy of Protozoan Diseases. Walter Reed Army Institute of Medicine, 1971

    • PubMed
    • Export Citation
  • 13

    Thomas F, Erhart A, D’Alessandro U, 2004. Can amodiaquine be used safely during pregnancy? Lancet Infect Dis 4 :235–239.

  • 14

    Olliaro P, Mussano P, Amodiaquine for treating malaria. Cochrane Database Syst Rev 2003:CD000016

  • 15

    Taylor WR, White NJ, 2004. Antimalarial drug toxicity: a review. Drug Saf 27 :25–61.

  • 16

    Pussard E, Verdier F, Faurisson F, Scherrmann JM, Le Bras J, Blayo MC, 1987. Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria. Eur J Clin Pharmacol 33 :409–414.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Ringwald P, Bickii J, Basco LK, 1998. Amodiaquine as the first-line treatment of malaria in Yaounde, Cameroon: presumptive evidence from activity in vitro and cross-resistance patterns. Trans R Soc Trop Med Hyg 92 :212–213.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Ringwald P, Bickii J, Basco LK, 1999. In vitro activity of dihydroartemisinin against clinical isolates of Plasmodium falciparum in Yaounde, Cameroon. Am J Trop Med Hyg 61 :187–192.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Caramello P, Canta F, Cavecchia I, Sergi G, Balbiano R, Ariaudo S, Audagnotto S, DiPerri G, 2005. Chemosusceptibility analysis of Plasmodium falciparum imported malaria in Italy. Diagn Microbiol Infect Dis 52 :107–112.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Graupner J, Gobels K, Grobusch MP, Lund A, Richter J, Haussinger D, 2005. Efficacy of amodiaquine in uncomplicated falciparum malaria in Nigeria in an area with high-level resistance to chloroquine and sulphadoxine/pyrimethamine. Parasitol Res 96 :162–165.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Molta NB, Oguche S, Pam SD, Omalu IC, Afolabi BM, Odujoko JB, Amajoh CN, Adeniji B, Wuyep VP, Ekanem OJ, 2003. Amodiaquine treatment of uncomplicated malaria in children, in an area of chloroquine-resistant Plasmodium falciparum in north-central Nigeria. Ann Trop Med Parasitol 97 :663–669.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Sendagire H, Kaddumukasa M, Ndagire D, Agutta C, Nassejje M, Pettersson M, Swedberg G, Kironde F, 2005. Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative. Acta Trop 95 :172–182.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Rwagacondo CE, Karema C, Mugisha V, Erhart A, Dujardin JC, Van Overmeir C, Ringwald P, D’Alessandro U, 2004. Is amodiaquine failing in Rwanda? Efficacy of amodiaquine alone and combined with artesunate in children with uncomplicated malaria. Trop Med Int Health 9 :1091–1098.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Basco LK, Same-Ekobo A, Ngane VF, Ndounga M, Metoh T, Ringwald P, Soula G, 2002. Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bull World Health Organ 80 :538–545.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Dinis DV, Schapira A, 1990. Comparative study of sulfadoxine-pyrimethamine and amodiaquine + sulfadoxine-pyrimethamine for the treatment of malaria caused by chloroquine-resistant Plasmodium falciparum in Maputo, Mozambique. Bull Soc Pathol Exot 83 :521–527; discussion 528

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Dorsey G, Njama D, Kamya MR, Cattamanchi A, Kyabayinze D, Staedke SG, Gasasira A, Rosenthal PJ, 2002. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 360 :2031–2038.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Gasasira AF, Dorsey G, Nzarubara B, Staedke SG, Nassali A, Rosenthal PJ, Kamy MR, 2003. Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68 :127–132.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Huang OL, Ouyang WC, Zhou JX, Wu Z, Zhang KY, Huang JK, Cai XZ, Pang XJ, Fu SG, Wang XF, et al., 1988. Effectiveness of amodiaquine, sulfadoxine-pyrimethamine, and combinations of these drugs for treating chloroquine-resistant falciparum malaria in Hainan Island, China. Bull World Health Organ 66 :353–358.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Menard D, Madji N, Manirakiza A, Djalle D, Koula MR, Talarmin A, 2005. Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with non-complicated malaria. Am J Trop Med Hyg 72 :581–585.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Mockenhaupt FP, Ehrhardt S, Dzisi SY, Teun Bousema J, Wassilew N, Schreiber J, Anemana SD, Cramer JP, Otchwemah RN, Sauerweim RW, Eggelte TA, Bienzle U, 2005. A randomized, placebo-controlled, double-blind trial on sulfadoxine-pyrimethamine alone or combined with artesunate or amodiaquine in uncomplicated malaria. Trop Med Int Health 10 :512–520.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Mutabingwa TK, Anthony D, Heller A, HallettR, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ, 2005. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365 :1474–1480.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Schapira A, Schwalbach JF, 1988. Evaluation of four therapeutic regimens for falciparum malaria in Mozambique, 1986. Bull World Health Organ 66 :219–226.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Schellenberg D, Kahigwa E, Drakeley C, Malende A, Wigayi J, Msokame C, Aponte JJ, Tanner M, Mshinda H, Menendez C, Alonso PL, 2002. The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 67 :17–23.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Staedke SG, Kamya MR, Dorsey G, Gasasira A, Ndeezi G, Charlebois ED, Rosenthal PJ, 2001. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358 :368–374.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Melander H, Ahlqvist-Rastad J, Meijer G, Beermann B, 2003. Evidence b(i)ased medicine–selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications. BMJ 326 :1171–1173.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Tierney JF, Stewart LA, 2005. Investigating patient exclusion bias in meta-analysis. Int J Epidemiol 34 :79–87.

  • 37

    Schulz KF, Grimes DA, 2002. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 359 :781–785.

Past two years Past Year Past 30 Days
Abstract Views 571 540 18
Full Text Views 217 2 0
PDF Downloads 39 2 0
 
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save